Nicotinic Receptor β2 Determines NK Cell-Dependent Metastasis in a Murine Model of Metastatic Lung Cancer

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Hao, Junwei ^a   Shi, Fu Dong ^a,b   Abdelwahab, Mohammed ^b   Shi, Samuel X ^b   Simard, Alain ^c   Whiteaker, Paul ^b   Lukas, Ronald ^b   Zhou, Qinghua ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

^c UNIVERSITÉ DE MONCTON   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NATURAL KILLER CELL RECEPTOR; NICOTINE; NICOTINIC RECEPTOR BETA2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE FUNCTION; LIGAND BINDING; LUNG METASTASIS; LYMPHOCYTE FUNCTION; MELANOMA METASTASIS; MOUSE; NATURAL KILLER CELL; NICOTINIC RECEPTOR BETA2 GENE; NONHUMAN; NUCLEOTIDE SEQUENCE;

ANIMALS; BASE SEQUENCE; DISEASE MODELS, ANIMAL; DNA PRIMERS; FEMALE; KILLER CELLS, NATURAL; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; NICOTINE; RECEPTORS, NICOTINIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84874561590     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057495     Document Type: Article

References (27)

1. Sopori M, (2002) Effects of cigarette smoke on the immune system. Nat Rev Immunol 2: 372-377.
2. Stampfli MR, Anderson GP, (2009) How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nat Rev Immunol 9: 377-384.
3. Wang H, Liao H, Ochani M, Justiniani M, Lin X, et al. (2004) Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 10: 1216-1221.
4. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, et al. (2003) Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421: 384-388.
5. de Jonge WJ, van der Zanden EP, The FO, Bijlsma MF, van Westerloo DJ, et al. (2005) Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 6: 844-851.
6. van Maanen MA, Lebre MC, van der Poll T, LaRosa GJ, Elbaum D, et al. (2009) Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice. Arthritis Rheum 60: 114-122.
7. Shi FD, Piao WH, Kuo YP, Campagnolo DI, Vollmer TL, et al. (2009) Nicotinic attenuation of central nervous system inflammation and autoimmunity. J Immunol 182: 1730-1739.
8. Hao J, Simard AR, Turner GH, Wu J, Whiteaker P, et al. (2010) Attenuation of CNS inflammatory responses by nicotine involves alpha7 and non-alpha7 nicotinic receptors. Exp Neurol.
9. Mian MF, Lauzon NM, Stampfli MR, Mossman KL, Ashkar AA, (2008) Impairment of human NK cell cytotoxic activity and cytokine release by cigarette smoke. J Leukoc Biol 83: 774-784.
10. Tollerud DJ, Clark JW, Brown LM, Neuland CY, Mann DL, et al. (1989) Association of cigarette smoking with decreased numbers of circulating natural killer cells. Am Rev Respir Dis 139: 194-198.
11. Lu LM, Zavitz CC, Chen B, Kianpour S, Wan Y, et al. (2007) Cigarette smoke impairs NK cell-dependent tumor immune surveillance. J Immunol 178: 936-943.
12. Ng AK, Travis LB, (2008) Subsequent malignant neoplasms in cancer survivors. Cancer J 14: 429-434.
13. Owens JC, Balogh SA, McClure-Begley TD, Butt CM, Labarca C, et al. (2003) Alpha 4 beta 2* nicotinic acetylcholine receptors modulate the effects of ethanol and nicotine on the acoustic startle response. Alcohol Clin Exp Res 27: 1867-1875.
14. Whiteaker P, Jimenez M, McIntosh JM, Collins AC, Marks MJ, (2000) Identification of a novel nicotinic binding site in mouse brain using [(125)I]-epibatidine. Br J Pharmacol 131: 729-739.
15. Lakshmikanth T, Burke S, Ali TH, Kimpfler S, Ursini F, et al. (2009) NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo. J Clin Invest 119: 1251-1263.
16. Werneck MB, Lugo-Villarino G, Hwang ES, Cantor H, Glimcher LH, (2008) T-bet plays a key role in NK-mediated control of melanoma metastatic disease. J Immunol 180: 8004-8010.
17. Robbins CS, Dawe DE, Goncharova SI, Pouladi MA, Drannik AG, et al. (2004) Cigarette smoke decreases pulmonary dendritic cells and impacts antiviral immune responsiveness. Am J Respir Cell Mol Biol 30: 202-211.
18. Hao J, Liu R, Piao W, Zhou Q, Vollmer TL, et al. (2010) Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology. J Exp Med 207: 1907-1921.
19. Marks MJ, Smith KW, Collins AC, (1998) Differential agonist inhibition identifies multiple epibatidine binding sites in mouse brain. J Pharmacol Exp Ther 285: 377-386.
20. Whiteaker P, McIntosh JM, Luo S, Collins AC, Marks MJ, (2000) 125I-alpha-conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain. Mol Pharmacol 57: 913-925.
21. McIntosh JM, Azam L, Staheli S, Dowell C, Lindstrom JM, et al. (2004) Analogs of alpha-conotoxin MII are selective for alpha6-containing nicotinic acetylcholine receptors. Mol Pharmacol 65: 944-952.
22. Lanier LL, (2008) Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 9: 495-502.
23. Raulet DH, Vance RE, (2006) Self-tolerance of natural killer cells. Nat Rev Immunol 6: 520-531.
24. Smyth MJ, Taniguchi M, Street SE, (2000) The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent. J Immunol 165: 2665-2670.
25. Jensen AA, Frolund B, Liljefors T, Krogsgaard-Larsen P, (2005) Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations. J Med Chem 48: 4705-4745.
26. Lukas RJ, Changeux JP, Le Novere N, Albuquerque EX, Balfour DJ, et al. (1999) International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol Rev 51: 397-401.
27. Piao WH, Campagnolo D, Dayao C, Lukas RJ, Wu J, et al. (2009) Nicotine and inflammatory neurological disorders. Acta Pharmacol Sin 30: 715-722.